Corporate Events

The company closed its plan on September 18, 2026.

From July 1, 2026 to September 18, 2026, the company has repurchased 468,500 shares, representing 1.61% for ¥1,512.83 million. With this, the company has completed the repurchase of 634,300 shares, representing 2.18% for ¥1,999.93 million under the buyback announced on May 13, 2026.

Riken Vitamin Co., Ltd. provided consolidated earnings guidance for the six months ending September 30, 2026 and fiscal year ending March 31, 2027. For six months, the company expects Net sales of JPY 49,500 million, Operating profit of JPY 3,600 million, Profit attributable to owners of parent of JPY 2,900 million, and Earnings per share of JPY 99.71. For the fiscal year, the company expects Net sales of JPY 100,000 million, Operating profit of JPY 7,100 million, Profit attributable to owners of parent of JPY 7,500 million, and Earnings per share of JPY 258.10.

Riken Vitamin Co., Ltd. reported earnings results for the first quarter ended June 30, 2026. For the first quarter, the company reported sales was JPY 25,133 million compared to JPY 23,257 million a year ago. Net income was JPY 1,869 million compared to JPY 1,825 million a year ago. Basic earnings per share from continuing operations was JPY 64.16 compared to JPY 61.16 a year ago.

Riken Vitamin Co., Ltd., ¥ 55.0, Cash Dividend, Sep-29-2026

From May 13, 2026 to June 30, 2026, the company has repurchased 165,800 shares, representing 0.57% for ¥487.09 million. With this, the company has completed the repurchase of 165,800 shares, representing 0.57% for ¥487.09 million under the buyback announced on May 13, 2026.

Riken Vitamin Co., Ltd. announced that they will report Q1, 2027 results on Aug 07, 2026

Riken Vitamin Co., Ltd. expected to report Q1 2027 results on August 14, 2026. This event was calculated by S&P Global (Created on May 26, 2026).

Riken Vitamin Co., Ltd. expects to pay second quarter end dividend of JPY 55.00 per share for the fiscal year ending March 31, 2027 as compared to JPY 55.00 per share paid a year ago. For the year end of fiscal year ending March 31, 2027, the company expects to pay dividend of JPY 55.00 per share as compared to JPY 55.00 per share payable to same period prior year.

Riken Vitamin Co., Ltd. announced year end dividend of JPY 55.00 per share for the fiscal year ended March 31, 2026 as compared to JPY 53.50 per share paid a year ago. Scheduled date for dividend payment is June 8, 2026.

Riken Vitamin Co., Ltd. provided consolidated earnings guidance for the six months ending September 30, 2026 and fiscal year ending March 31, 2027. For six months, the company expects Net sales of JPY 49,500 million, Operating profit of JPY 3,600 million, Profit attributable to owners of parent of JPY 2,900 million, and Earnings per share of JPY 99.36. For the fiscal year, the company expects Net sales of JPY 100,000 million, Operating profit of JPY 7,100 million, Profit attributable to owners of parent of JPY 7,500 million, and Earnings per share of JPY 256.96.

Riken Vitamin Co., Ltd., Board Meeting, May 20, 2026. Agenda: To consider and approve Regarding Dividend of Surplus.

The Board of Directors of Riken Vitamin Co., Ltd. has authorized a buyback plan on May 13, 2026.

Riken Vitamin Co., Ltd. (TSE:4526) announces a share repurchase program. Under the program, the company will repurchase up to 900,000 shares, representing 3.08% of its issued share capital, for ¥2,000 million. The purpose of the program is to improve capital efficiency and enhance shareholder returns. The program will expire on September 30, 2026. As of March 31, 2026, the company had 29,187,811 shares (excluding treasury stock) and 1,517,289 shares in treasury.

Riken Vitamin Co., Ltd., Annual General Meeting, Jun 23, 2026.

Riken Vitamin Co., Ltd., Board Meeting, May 13, 2026. Agenda: To consider the Notice Regarding Acquisition of Own Shares.

Riken Vitamin Co., Ltd. announced that they will report fiscal year 2026 results on May 13, 2026

Riken Vitamin Co., Ltd., 2026 Earnings Call, May 21, 2026

Riken Vitamin Co., Ltd., Board Meeting, Jun 23, 2026. Agenda: To consider and approve the changes will be officially decided after being appointed at the 90th Annual General Meeting of Shareholders.

Riken Vitamin Co., Ltd., Board Meeting, Apr 27, 2026. Agenda: To consider and approve the resolved to implement the following planned changes in representative director and directors.

ITOCHU Corporation (TSE:8001) proposed to acquire the remaining 47.54% stake in ITOCHU-SHOKUHIN Co., Ltd. (TSE:2692) from group of shareholders for ¥78.4 billion on February 25, 2026. The consideration consists of ¥13,000 per common share in cash. The Tender Offeror has set 1,801,900 shares as the minimum number of shares to be purchased in the Tender Offer (ownership ratio: 14.20%). If the total number of shares, etc., tendered in the Tender Offer is less than the minimum number of shares to be purchased as set out above, the Tender Offeror will not purchase any of the Tendered Shares, Etc. Conversely, the Tender Offeror has not set an upper limit on the number of shares to be purchased in the Tender Offer, and, if the total number of Tendered Shares, Etc. meets or exceeds the minimum number of shares to be purchased, the Tender Offeror will purchase all of the Tendered Shares, Etc. As of As of March 17, 2026, the Tender Offeror entered into respective tender contracts with ASAHI BREWERIES, LTD., Hagoromo Foods Corporation, Morinaga & Co., Ltd., Umios Corporation, S&B FOODS INC., Meiji Co., Ltd., Kewpie Corporation, The Nisshin OilliO Group, Ltd., NIPPN CORPORATION, Nestlé Japan Ltd., Gekkeikan Sake Company, Limited, Asahi Soft Drinks Co., Ltd., Ozeki Co., Ltd., Tatsuuma-Honke Brewing Co. Ltd., HAKUTSURU SAKE BREWING CO.,LTD., BULL-DOG SAUCE CO.,LTD., Sumitomo Mitsui Trust Bank, Limited, and YUASA FUNASHOKU Co., Ltd., who are shareholders of the Target Company, whereby they agreed to tender all of their Target Company Shares in the Tender Offer and not to withdraw their tenders. ITOCHU Corporation (TSE:8001) completed the acquisition of remaining 47.54% stake in ITOCHU-SHOKUHIN Co., Ltd. (TSE:2692) from group of shareholders on April 9, 2026. On closing of the offer, 4,768,910 shares were tendered and the balance will be acquired through the Squeeze-Out Procedures.

The company closed its plan on March 23, 2026.

From January 1, 2026 to March 23, 2026, the company has repurchased 172,800 shares, representing 0.59% for ¥525.36 million. With this, the company has completed the repurchase of 696,500 shares, representing 2.35% for ¥1,999.89 million under the buyback announced on April 30, 2025.

Riken Vitamin Co., Ltd. reported earnings results for the nine months ended December 31, 2025. For the nine months, the company reported sales was JPY 72,503 million compared to JPY 72,852 million a year ago. Net income was JPY 5,949 million compared to JPY 5,834 million a year ago. Basic earnings per share from continuing operations was JPY 200.75 compared to JPY 192.17 a year ago.

From October 1, 2025 to December 31, 2025, the company has repurchased 213,700 shares, representing 0.72% for ¥611.51 million. With this, the company has completed the repurchase of 523,700 shares, representing 1.76% for ¥1,474.53 million under the buyback announced on April 30, 2025.

Riken Vitamin Co., Ltd. expected to report Fiscal Year 2026 results on May 15, 2026. This event was calculated by S&P Global (Created on May 14, 2026).

Riken Vitamin Co., Ltd. announced that they will report Q3, 2026 results on Feb 12, 2026

Riken Vitamin Co., Ltd. provided consolidated earnings guidance for the year ending March 31, 2026. For the year, the company expects net sales of JPY 100,000 million; operating profit of JPY 8,500 million; profit attributable to owners of parent of JPY 8,200 million and earnings per share of JPY 276.51.

Riken Vitamin Co., Ltd. expected to report Q3 2026 results on February 13, 2026. This event was calculated by S&P Global (Created on November 13, 2025).

Riken Vitamin Co., Ltd., ¥ 55.0, Cash Dividend, Mar-30-2026

Riken Vitamin Co., Ltd., Board Meeting, Oct 27, 2025. Agenda: To consider the Notice Regarding Dividend of Surplus (Interim Dividend).

Riken Vitamin Co., Ltd., H1 2026 Earnings Call, Nov 25, 2025

From July 1, 2025 to September 30, 2025, the company has repurchased 216,400 shares, representing 0.73% for ¥619.98 million. With this, the company has completed the repurchase of 310,000 shares, representing 1.04% for ¥863.02 million under the buyback announced on April 30, 2025.